| |
| |
|
| Insider
Information: |
Winningham Rick E |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,688,476 |
|
|
Indirect Shares
|
96,467 |
|
|
| Direct
Value |
$31,367,366 |
|
|
|
Indirect Value
|
$879,779 |
|
|
| Total
Shares |
2,784,943 |
|
|
| Total
Value |
$32,247,145 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -15.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Innoviva Inc |
INVA |
Director |
2014-08-15 |
825,391 |
2008-01-29 |
0 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
10,444 |
2012-01-11 |
0 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
|
2024-05-15 |
1,852,641 |
2024-05-15 |
96,467 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-05-15 |
4 |
A |
$9.85 |
$20,370 |
D/D |
2,068 |
1,852,641 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
1,850,573 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,900 |
3,900 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,900 |
1,550,573 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-15 |
4 |
A |
$8.64 |
$23,363 |
D/D |
2,704 |
1,561,473 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-20 |
4 |
D |
$8.92 |
$331,788 |
D/D |
(37,196) |
1,558,769 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-11-20 |
4 |
D |
$10.37 |
$163,887 |
D/D |
(15,804) |
1,595,965 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-08-20 |
4 |
D |
$9.70 |
$153,299 |
D/D |
(15,804) |
1,611,769 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2023-08-14 |
4 |
S |
$138.16 |
$171,455 |
D/D |
(1,241) |
10,444 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,075 |
11,685 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-05-20 |
4 |
D |
$11.21 |
$177,163 |
D/D |
(15,804) |
1,627,573 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
330,000 |
1,643,377 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-02-20 |
4 |
D |
$10.44 |
$390,665 |
D/D |
(37,420) |
1,313,377 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-12-14 |
4 |
S |
$11.19 |
$559,500 |
D/D |
(50,000) |
1,350,797 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-12-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,000 |
1,400,797 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-11-20 |
4 |
D |
$10.85 |
$171,473 |
D/D |
(15,804) |
1,409,797 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-08-19 |
4 |
D |
$9.34 |
$147,609 |
D/D |
(15,804) |
1,424,784 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2022-08-08 |
4 |
S |
$152.32 |
$165,879 |
D/D |
(1,089) |
8,610 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,561 |
9,699 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-05-20 |
4 |
D |
$8.74 |
$96,359 |
D/D |
(11,025) |
1,440,588 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
170,000 |
1,449,300 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-02-18 |
4 |
D |
$9.61 |
$218,243 |
D/D |
(22,710) |
1,279,300 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2021-08-20 |
4 |
D |
$14.05 |
$160,226 |
D/D |
(11,404) |
1,313,414 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2021-08-06 |
4 |
S |
$147.96 |
$193,236 |
D/D |
(1,306) |
7,138 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2021-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,246 |
8,444 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
